Product Details
Omeprazole Capsules IP
Veromep-20 Capsules meet Indian Pharmacopoeia (IP) standards for the management of acid-related gastrointestinal conditions. Specifically, each capsule delivers Omeprazole IP at 20mg. As a result, it offers effective, sustained acid suppression for the treatment and prevention of acid-related disorders.
The capsules contain:
- Omeprazole IP (20mg) – A proton pump inhibitor that irreversibly blocks the H+/K+-ATPase enzyme in gastric parietal cells. Consequently, it suppresses gastric acid secretion, relieving symptoms of acid reflux and supporting healing of the oesophageal and gastric lining.
Physicians prescribe Veromep-20 for the treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease, and Zollinger-Ellison syndrome, as well as for the prevention of NSAID-associated gastric ulcers. In addition, its once-daily oral dosing supports simple, effective long-term management of acid-related conditions. Because of this profile, Veromep-20 suits gastroenterology and general practice settings managing chronic and acute acid-related disorders.
Key Features:
- Overall, this IP-compliant formulation guarantees pharmaceutical-grade purity
- Additionally, the oral capsule format supports easy, once-daily dosing
- Furthermore, each capsule delivers precise, validated dosage accuracy at 20mg
- Notably, rigorous quality testing backs every stage of manufacturing
- Beyond that, blister packaging protects capsule integrity against light
- Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies